+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical observations concerning piracetam treatment of patients after craniocerebral injury



Clinical observations concerning piracetam treatment of patients after craniocerebral injury



Przeglad Lekarski 56(2): 119-120



Piracetam (Nootropil) is a cytoprotective to brain tissue and improving cerebral blood flow medicine. In the Department of Neurotraumatology we investigated results of piracetam treatment in a group of 100 succeeding patients admitted between 1995-96 due to craniocerebral injury. High doses (24-30 g per day) of this medicine have a positive effect on final result of treatment, when treatment is initiated immediately after the injury and described conditions are abided. We also showed usefulness of piracetam treatment in posthospital management.

Accession: 045538355

Download citation: RISBibTeXText

PMID: 10375942


Related references

Clinical diagnosis and treatment of abdominal visceral injury complicated by craniocerebral injury. Chinese Journal of Traumatology 9(2): 105-107, 2006

The analysis on risk factors and clinical treatment of craniocerebral injury concurrent with acute kidney injury. Cell Biochemistry and Biophysics 71(1): 199-204, 2015

Sequelae of closed craniocerebral trauma and the efficacy of piracetam in its treatment in adolescents. Neuroscience and Behavioral Physiology 39(4): 323-328, 2009

Effect of piracetam on the functional activity of the brain in patients with craniocerebral injuries. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 88(5): 42-48, 1988

The effect of piracetam on the color-discrimination function of retina in patients with consequences of craniocerebral traumas. Eksperimental'naya i Klinicheskaya Farmakologiya 66(4): 6-8, 2003

Clinical analysis on 149 old patients with craniocerebral injury. Chinese Journal of Traumatology 4(1): 28-30, 2001

Clinical monitoring for patients with severe craniocerebral injury. Zhonghua Hu Li Za Zhi 31(5): 270-272, 1996

The clinical manifestations of craniocerebral injury in senile patients. Zhurnal Nevrologii i Psikhiatrii Imeni S S Korsakova 93(2): 37-39, 1993

The surgical treatment of patients with craniocerebral injury. American Journal of Surgery 59(2): 272-291, 1943

Clinical characteristics of craniocerebral injury in patients with arterial hypertension. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 88(5): 8-10, 1988

Treatment of femoral fractures in patients with craniocerebral injury. International Surgery 67(4 Suppl): 556-558, 1982

The use of laser therapy in the treatment of patients with craniocerebral injury. Kazanskii Meditsinskii Zhurnal 80(6): 441-442, 1999

Immunological and clinical aspects of cell therapy in the treatment of aftereffects of craniocerebral injury. Bulletin of Experimental Biology and Medicine 141(1): 121-123, 2006

Pharmacoeconomic Analysis of Treatment Patients With Craniocerebral Injury In Ukraine. Value in Health 18(7): A669, 2015

Diagnosis and treatment of the DIC syndrome in patients with grave craniocerebral injury. Anesteziologiya i Reanimatologiya 0(4): 29-33, 1995